NASDAQ:GMVD G Medical Innovations (GMVD) Stock Forecast, Price & News $0.40 -0.01 (-2.24%) (As of 10:56 AM ET) Add Compare Share Share Today's Range$0.39▼$0.4150-Day Range$0.37▼$2.6952-Week Range$0.34▼$41.30Volume71,981 shsAverage Volume997,023 shsMarket Capitalization$785,372.00P/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About G Medical Innovations (NASDAQ:GMVD) StockG Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.Read More Receive GMVD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for G Medical Innovations and its competitors with MarketBeat's FREE daily newsletter. Email Address GMVD Stock News HeadlinesMay 19, 2023 | finance.yahoo.comG Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Minimum Bid Price NotificationApril 18, 2023 | finance.yahoo.comG MEDICAL UPDATES ON PATIENT ENROLLMENT GROWTH FOR ITS HOME MONITORING SERVICES OF 194% FROM JANUARY THROUGH APRIL 2023, AS COMPARED TO THE SAME PERIOD IN 2022June 1, 2023 | Edge On The Street (Ad)Graphite versus Lithium - What Investors Should KnowOver 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.April 7, 2023 | americanbankingnews.comInsider Selling: G Medical Innovations Holdings Ltd (NASDAQ:GMVD) Major Shareholder Sells 437,500 Shares of StockApril 6, 2023 | americanbankingnews.comAwm Investment Company, Inc. Sells 300,000 Shares of G Medical Innovations Holdings Ltd (NASDAQ:GMVD) StockApril 4, 2023 | finance.yahoo.comG Medical Innovations Holdings Ltd. Announces Closing of Public OfferingApril 2, 2023 | nasdaq.comG Medical Innovations Falls 43% After Announcing Pricing Of 12 Mln Public OfferingMarch 31, 2023 | finance.yahoo.comG Medical Innovations Holdings Ltd. Announces Pricing of Public OfferingJune 1, 2023 | Edge On The Street (Ad)Graphite versus Lithium - What Investors Should KnowOver 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.March 29, 2023 | finance.yahoo.comG MEDICAL INNOVATIONS AND ADVENTHEALTH IN JOINT COLLABORATION TO PROVIDE INNOVATIVE REMOTE PATIENT MONITORING SOLUTIONS FOR ADVENTHEALTH PATIENTS IN CENTRAL FLORIDAMarch 27, 2023 | msn.comG Medical Innovations, MiCare Path sign collaboration agreement for their solutionsFebruary 18, 2023 | finance.yahoo.comG Medical Innovations Holdings Ltd Announces Nasdaq Staff Listing Determination; Plans to Request HearingFebruary 13, 2023 | finance.yahoo.comG Medical Innovations announces receipt of patent from USPTO for vital signs sensorsJanuary 30, 2023 | benzinga.comWhat's Going On With G Medical Innovations Stock Today?January 30, 2023 | marketwatch.comG Medical Innovations Gets Notice of Patent Issuance For Vital Signs SensorsJanuary 30, 2023 | finance.yahoo.comG Medical Innovations announces receiving notice of patent issuance from the USPTO for vital signs sensorsJanuary 11, 2023 | benzinga.comG Medical Innovations Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 98.6%January 11, 2023 | benzinga.comG Medical Innovations Holdings Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 105%January 11, 2023 | marketwatch.comG Medical Innovations Up 83% on Heavy VolumeDecember 5, 2022 | finance.yahoo.comG Medical Innovations to announce receiving of 2 (two) granted patents from the USPTO for its Prizma care and other physiological sensors developed by the company.November 22, 2022 | finance.yahoo.comG Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Notice of Deficiency with Nasdaq Continued Listing RequirementsOctober 7, 2022 | benzinga.comSecurity Innovation offers free, hands-on software security trainingOctober 6, 2022 | finance.yahoo.comG Medical Innovations is introducing a Monkeypox consumer home health test kit, along with 30 new direct to consumer home health testing kits with 24 to 48 hours resultsAugust 9, 2022 | benzinga.comMedical Marijuana Market Worth USD 248.42 Billion by 2030 at 31.97% CAGR - Report by Market Research Future (MRFR)June 17, 2022 | seekingalpha.comNasdaq sends non-compliance notice to G Medical Innovations HoldingsMay 21, 2022 | benzinga.comG Medical Innovations (NASDAQ:GMVD), Earnings Estimates, EPS, and RevenueMay 20, 2022 | seekingalpha.comG Medical Innovations announces $1M buyback programSee More Headlines GMVD Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GMVD Company Calendar Today6/01/2023Next Earnings (Estimated)8/15/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:GMVD CUSIPN/A CIK1760764 Webgmedinnovations.com Phone972-8958-4777FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.22 Quick Ratio0.19 Sales & Book Value Annual Sales$4.42 million Price / Sales0.17 Cash FlowN/A Price / Cash FlowN/A Book Value($3.21) per share Price / Book-0.12Miscellaneous Outstanding Shares1,960,000Free Float1,235,000Market Cap$764,596.00 OptionableNot Optionable BetaN/A Key ExecutivesDr. Yacov Geva (Age 72)Pres, CEO, MD & Exec. Director Comp: $360kMr. Igor BluvsteinChief Financial OfficerMr. Benny Tal (Age 63)VP of R&D and CTO Mr. Oded Shahar (Age 62)Sr. Investment Banker and Sr. VP of Merger & Acquisition Ms. Dror Nuriel-Roth (Age 47)Exec. VP of US Operations Mr. Kobi Ben Efraim (Age 67)Controller Mr. Brett TuckerCompany Sec.More ExecutivesKey CompetitorsAssureNASDAQ:IONMQuoin PharmaceuticalsNASDAQ:QNRXBiodexa PharmaceuticalsNASDAQ:BDRXTC BiopharmNASDAQ:TCBPCancer GeneticsNASDAQ:CGIXView All CompetitorsInsiders & InstitutionsSabby Management LLCBought 1,350,000 shares on 5/16/2023Ownership: 68.737%Perkins Capital Management Inc.Bought 200,000 shares on 5/9/2023Ownership: 10.204%Barclays PLCBought 56,001 shares on 5/4/2023Ownership: 2.851%Awm Investment Company, Inc.Sold 300,000 sharesTotal: $219,000.00 ($0.73/share)Awm Investment Company, Inc.Sold 437,500 sharesTotal: $446,250.00 ($1.02/share)View All Insider TransactionsView All Institutional Transactions GMVD Stock - Frequently Asked Questions How have GMVD shares performed in 2023? G Medical Innovations' stock was trading at $3.28 on January 1st, 2023. Since then, GMVD shares have decreased by 88.1% and is now trading at $0.3901. View the best growth stocks for 2023 here. When is G Medical Innovations' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 15th 2023. View our GMVD earnings forecast. When did G Medical Innovations' stock split? G Medical Innovations shares reverse split before market open on Saturday, November 19th 2022. The 1-35 reverse split was announced on Saturday, November 19th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Saturday, November 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did G Medical Innovations IPO? (GMVD) raised $8 million in an IPO on Friday, June 25th 2021. The company issued 3,000,000 shares at a price of $5.00-$0.00 per share. What is G Medical Innovations' stock symbol? G Medical Innovations trades on the NASDAQ under the ticker symbol "GMVD." Who are G Medical Innovations' major shareholders? G Medical Innovations' stock is owned by a number of institutional and retail investors. Top institutional investors include Sabby Management LLC (68.74%), Perkins Capital Management Inc. (10.20%) and Barclays PLC (2.85%). View institutional ownership trends. How do I buy shares of G Medical Innovations? Shares of GMVD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is G Medical Innovations' stock price today? One share of GMVD stock can currently be purchased for approximately $0.39. How much money does G Medical Innovations make? G Medical Innovations (NASDAQ:GMVD) has a market capitalization of $764,596.00 and generates $4.42 million in revenue each year. How can I contact G Medical Innovations? G Medical Innovations' mailing address is 5 OPPENHEIMER ST., REHOVOT L3, 7670105. The official website for the company is gmedinnovations.com. The company can be reached via phone at 972-8958-4777. This page (NASDAQ:GMVD) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding G Medical Innovations Holdings Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.